Diabetes mellitus due to olanzapine use: A case report;Olanzapin'e baǧli diabetes mellitus: Bir olgu sunumu

Klinik Psikofarmakoloji Bulteni

Volumn 13, Issue 2, 2003, Pages 94-96

  Danaci, Ayşen Esen ^a   Mizrak, Selin ^a   Hekimsoy, Zeliha ^a   Içelli, Ilkin ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Diabetes mellitus; Olanzapine; Schizophrenia; Side effect

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; GLUCOSE; OLANZAPINE; SEROTONIN ANTAGONIST;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; ORTHOSTATIC HYPOTENSION; RISK FACTOR; SCHIZOPHRENIA; SEDATION;

EID: 0038710539     PISSN: 10177833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alvarez E, Bobes J, Gomez JC, Sacristan JA, Canas F, Carrasco JL, Gascon J, Gibert J, Guttierez M. Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study. Eur Neuropsychopharmacol 2003; 13: 39-48
2. Inada T, Yagi G, Miura S. Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol. Schizophr Res 2002; 57: 227-238
3. Bhana N, Foster RH, Olney R, Plosker GL. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 2001; 61: 111-161
4. Turrone P, Kapur S, Seeman MV, Flist AJ. Elevation of prolactin levels by atypical antipsychotics. Am J Psych 2002; 159: 133-135
5. Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. Schizophr Res 2002; 56: 11-17
6. Lykouras L, Markianos M, Hatzimanolis J, Oulis P. Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 507-518
7. Stahl MS. Essentials Psycopharmacology Second Edition. Cambridge, Cambridge University Press, 2000; 434-435
8. Van Kammen DP, Marder SR Serotonin-dopamin antagonists. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock's comprehensive textbook of psychiatry 7th Edition. Philadelphia, Lippincott Williams & Wilkins, 2000:2455-2473
9. Bernardo M, Parrelado E, Lomena F, Catafau AM, Font M, Gomez JC, Lopez-Carrero C, Gutierrez F, Paria J, Salamero M. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blokade in schizophrenic patients: a baseline-endpoint. Psychiatry Res 2001; 107: 87-97
10. Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, Revicki D, Buchanan RW. An assesment of the independent effects of olanzapine and risperidone exposure on the risk of hiperlipidemia in schizophrenic patients. Arch Gen Psychiatry 2002; 59: 1021-1026
11. Gianfrancesco FD, Grogg AL, Mahmoud RA; Wang RH, Nasrallah HA. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 2002; 63: 920-930
12. Ananth J, Venkatesh R, Brugoyne K, Gunatilake S. Atypical antipsychotic drug use and diabetes. Psychother Psychosom 2002; 71: 244-254
13. Koro CE, Fedder DO, L'Italien GJ, Weiss SS, Magder LS; Kreyenbuhl J, Revicki DA, Buchanan RW. Assesment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ 2002; 325: 243
14. Meatherall R, Younes J. Fatality from olanzapine induced hyperglycemia. J Forensic Sci 2002; 47: 893-896
15. Koller EA, Doraiswamy PM. Olanzapine-associated diabetes mellitus. Pharmacotherapy 2002; 22: 841-852
16. Ramankutty G. Olanzapine- induced destabilization of diabetes in the absence of weight gain. Acta Psychiatr Scand 2002; 105: 235-236
17. Haupt DW, Newcomer JW. Hyperglycemia and antipsychotic medications. J Clin Psychiatry 2001; 62 (Suppl 27): S15-S26
18. Henderson DC. Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence? CNS Drugs 2002; 16: 77-89
19. The Expert Committee on the diagnosis and classification of diabettes mellitus. Report of the Expert committee on the Diagnosis and classification of Diabetes Mellitus. Diabetes Care 2003; 26 (Suppl 1): S5-S20
20. Buse JB. Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetes. J Clin Psychiatry 2002; 63 (Suppl 4): S37-S41
21. Lebovitz HE. Diagnosis, classification, and patogenesis of diabettes mellitus. J Clin Psychiatry 2001; 62 (Suppl 27): S5-S9
22. Lebovitz HE. Insulin resistance and the Insulin Resistance Syndrome. In. Ebovitz HE, editor Insulin Resistance Canada; Science Press 2002:1-15